Eve Krous
Pulmonary hypertension is a life-threatening condition characterized by high blood pressure in the pulmonary arteries, leading to heart failure and other complications. Pharmacological agents are the primary mode of treatment for pulmonary hypertension, and new agents are continuously being developed and studied to improve patient outcomes. In this assessment, we review the current literature and analyze clinical trials to evaluate the efficacy of new pharmacological agents in the treatment of pulmonary hypertension. We discuss the potential benefits and limitations of these new agents and provide clinicians and patients with a better understanding of the available treatment options.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 